Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 3 Interventional Results available

A Study of Ixekizumab (LY2439821) in TNF Inhibitor Experienced Participants With Radiographic Axial Spondyloarthritis

ClinicalTrials.gov ID: NCT02696798

Public ClinicalTrials.gov record NCT02696798. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Jul 22, 2026, 2:22 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Multicenter, Randomized, Double-Blind, Placebo- Controlled 16-Week Study Followed by Long-Term Evaluation of Efficacy and Safety of Ixekizumab (LY2439821) in TNFi-Experienced Patients With Radiographic Axial Spondyloarthritis

Study identification

NCT ID
NCT02696798
Recruitment status
Completed
Study type
Interventional
Phase
Phase 3
Lead sponsor
Eli Lilly and Company
Industry
Enrollment
316 participants

Conditions and interventions

Interventions

  • Ixekizumab Drug
  • Placebo Drug

Drug

Eligibility (public fields only)

Age range
18 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Apr 11, 2016
Primary completion
May 17, 2018
Completion
May 2, 2019
Last update posted
Jun 16, 2020

2016 – 2019

United States locations

U.S. sites
27
U.S. states
19
U.S. cities
27
Facility City State ZIP Site status
Arizona Arthritis Research, PLC Phoenix Arizona 85032
Rheumatology Center of San Diego Escondido California 92025
Care Access Research - Huntington Beach Huntington Beach California 92648
Desert Medical Advances Palm Desert California 92260
Arthritis Assoc. & Osteoporosis Ctr of Colorado Springs, LLC Colorado Springs Colorado 80920
Denver Arthritis Center Denver Colorado 80230
Clinical Research Center of CT/NY Danbury Connecticut 06810
Arthritis Rheumatic Disease Specialties Aventura Florida 33180
Sarasota Arthritis Center Sarasota Florida 34239
Marietta Rheumatology Marietta Georgia 30060
St Luke's Clinic - Intermountain Orthopaedics Boise Idaho 83702
Institute of Arthritis Research Idaho Falls Idaho 83404
Center for Arthritis & Osteoporosis Elizabethtown Kentucky 42701
Klein and Associates MD, PA Cumberland Maryland 21502
Osteoporosis And Clinical Trial Center Hagerstown Maryland 21740
Arthritis Consultants St Louis Missouri 63141
The Center for Rheumatology Albany New York 12203
Shanahan Rheumatology & Immunotherapy Raleigh North Carolina 27617
Oregon Health and Science University Portland Oregon 97239
Altoona Center for Clinical Research Duncansville Pennsylvania 16635
Articularis Healthcare Group, INC dba Columbia Arthritis Ctr Columbia South Carolina 29204
Low Country Research Center North Charleston South Carolina 29406
Univ of Texas Health Science Center - Houston Houston Texas 77030
Southwest Rheumatology, P.A. Mesquite Texas 75150
Center for Arthritis and Rheumatic Diseases, PC Chesapeake Virginia 23320
Arthritis Northwest Rheumatology Spokane Washington 99204
Rheumatology and Immunotherapy Center Franklin Wisconsin 53132

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 72 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT02696798, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Jun 16, 2020 · Synced Jul 22, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT02696798 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →